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proximately 100 amino acid domains were originallyEunjoon Kim,† Morgan Sheng,†
identified based on repeated regions of sequence simi-and Roderick MacKinnon*‡
larity in the brain synaptic protein PSD-95, the Drosoph-*Laboratory of Molecular Neurobiology and Biophysics
ila septate junction protein Discs-Large, and the epithe-The Rockefeller University
lial tight junction protein ZO1. In these proteins, threeNew York, New York 10021
PDZ domains in the N-terminal half of the polypeptideand Department of Neurobiology
are followed by an Src homology 3 (SH3) domain and aHarvard Medical School
C-terminal region homologous to the yeast guanylateBoston, Massachusetts 02115
kinase enzyme (Cho et al., 1992; Woods and Bryant,†Howard Hughes Medical Institute
1991; Willott et al., 1993). In addition to this growingMassachusetts General Hospital
family, which also includes SAP97/hdlg (Lue et al., 1991;Department of Neurobiology
Muller et al., 1995), p55 (Ruff et al., 1991), and ZO2Harvard Medical School
(Jesaitis and Goodenough, 1994), PDZ domains are alsoBoston, Massachusetts 02114
found in different domain contexts in a variety of other
proteins, including protein tyrosine phosphatase (Sato
et al., 1995), a putative calmodulin-dependent kinase
Summary (Hata et al., 1996), neuronal nitric oxide synthase (nNOS)
(Hall et al., 1994), the dystrophin-associated syntrophins
Modular PDZ domains, found in many cell junction– (Adams et al., 1993; Ahn et al., 1994; Yang et al., 1994) as
associated proteins, mediate the clustering of mem- well as many of unknown function involved inDrosophila
brane ion channels by binding to their C-terminus. development (Klingensmith et al., 1994; Theisen et al.,
The X-ray crystallographic structures of the third PDZ 1994; Miyamoto et al., 1995).
domain from the synaptic protein PSD-95 in complex An important function of PDZ domains was implicated
when the N-terminal two PDZ domains (PDZ-1 andwith and in the absence of its peptide ligand have been
PDZ-2) of PSD-95 and its close relatives were shown todetermined at 1.8 A˚ and 2.3 A˚ resolution, respectively.
act as specific binding modules for the peptide motifThe structures reveal that a four-residue C-terminal
(Thr/Ser-X-Val) found at the very C-terminus of Shaker-stretch (X-Thr/Ser-X-Val-COO2) engages the PDZ do-
type K1 channels (Kim et al., 1995) and of NR2 subunitsmain through antiparallel main chain interactions with
of N-methyl-D-aspartic acid (NMDA) receptor ion chan-a b sheet of the domain. Recognition of the terminal
nels (Kornau et al., 1995; Niethammer et al., 1996). Thecarboxylate group of the peptide is conferred by a
interaction between the PDZ domains of PSD-95 andcradle of main chain amides provided by a Gly-Leu-
the C-terminus of K1 channel subunits results in theGly-Phe loop as well as by an arginine side chain.
coclustering of both proteins when they are coex-Specific side chain interactions and a prominent hy-
pressed in heterologous cells. Furthermore, Shaker-drophobic pocket explain the selective recognition of
type K1 channels and NMDA receptor ion channels colo-the C-terminal consensus sequence.
calize with PSD-95 in the mammalian brain. In further
support of a membrane protein localization function,
Introduction mutations in Discs-Large, the Drosophila homolog of
PSD-95, cause abnormal morphology at synapses
Ion channels and receptors are not distributed randomly where the protein is known to occur (Lahey et al., 1994).
on thesurface of cells, but rather are localized to regions In addition to their interaction with the C-terminus of
designed for specific functions. For example, at the neu- ion channels and receptors, PDZ domains also form
romuscular junction, aggregates of acetylcholine recep- apparently specific homophilic associations with other
tor ion channels in the postsynaptic membrane ensure PDZ domains. The second PDZ domain of PSD-95 and
that a burst of acetylcholine released from the nerve the single PDZ domain of syntrophin bind the unique
terminal will initiate muscle cell depolarization and N-terminal PDZ domain of nNOS; these interactions,
contraction. Similarly, in the central nervous system, respectively, bring nNOS in closeproximity to the NMDA
localization of specific ion channels and other mem- receptor channel in neuronal synapses and mediate the
brane-associated proteins at the pre- and postsynaptic association of nNOS with sarcolemmal membranes in
skeletal muscle (Brenman et al., 1995, 1996).membranes is essential for the proper transfer of electri-
PDZ domains have thus recently emerged as novelcal signals from one neuron to the next.
modules for specific protein–protein binding, importantRecently, a novel modular domain for protein–protein
not only in the clustering of membrane proteins, but alsointeraction has been identified in a diverse set of pro-
in linking signaling molecules in a multiprotein complexteins that are typically associated with cell junctions,
at specialized membrane sites. Understanding the func-including synapses of the central nervous system.
tion and specificity of these protein modules requiresTermed PDZ domains (but also known as Discs-Large
detailed knowledge of their structure. Here we present
the structures of a PDZ domain, the third PDZ domain
(PDZ-3) from the brain synaptic protein PSD-95. Struc-‡Present address: The Rockefeller University, 1230 York Avenue,
New York, New York 10021. tures of the domain in complex with peptide and in the
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absence of peptide were determined by X-ray crystal-
lography at 1.82 A˚ and 2.30 A˚, respectively. Together,
these two structures reveal the mechanism by which a
PDZ domain recognizes and binds to the consensus
sequence found at the C-terminus of several different
membrane proteins.
Results and Discussion
Structure Determination of the Complexed
and Peptide-Free PDZ Domains
This study was carried out on PDZ-3 of PSD-95, corre-
sponding to amino acids 302–402 (Cho et al., 1992). The
protein was expressed as a fusion protein in Escherichia
coli, cleaved, purified, and crystallized. The structure
of the peptide-free domain was solved using multiple
isomorphous replacement. Crystals of the PDZ-3–pep-
tide complex were grown in the presence of a nine-
residue peptide (Thr-Lys-Asn-Tyr-Lys-Gln-Thr-Ser-Val)
corresponding to the C-terminal residues of a PDZ-3-
interacting protein identified using a yeast two-hybrid
screen (M. S., unpublished data). The last three residues
Figure 1. Ribbon Diagram Showing the Three-Dimensional Fold ofin the sequence conform to the previously described
the PDZ-3 Domain from PSD-95 Corresponding to ResiduesPDZ domain–binding motif Thr/Ser-X-Val (Kim et al.,
309–3931995; Kornau et al., 1995; Niethammer et al., 1996). The
The peptide (yellow) inserts between the bB strand and aB helixstructure of the complex was solved using difference
and forms an antiparallel b sheet with bB. The connecting loopFourier analysis following a rigid body and positional
between bA and bB is involved in binding the peptide C-terminus
refinement using thepeptide-free model. Thefinal model and therefore is designated the carboxylate-binding loop. Residues
of the peptide-free domain was refined to 2.30 A˚ with outside the domain that were present in the crystal structure have
an R value of 21.4% (Rfree 5 31.5%), and the complex been omitted in this and subsequent figures (see Experimental Pro-
cedures). This picture was drawn using MOLSCRIPT (Kraulis, 1991)was refined to 1.82 A˚ with an R value of 20.7% (Rfree 5
and Raster3D (Bacon and Anderson, 1988).27.8%).
Structure of a PDZ Domain redirect the main chain. Conservation of these structural
residues indicates that the overall fold will be the sameThe PDZ domain contains eight segments of secondary
structure, six b strands, and two a helices (Figure 1). across the PDZ domain family.
The domain approximates a six-strand b sandwich, with
one of the strands (bD) participating in both sheets. Molecular Basis of Peptide Recognition
The C-terminal four residues of the peptide are veryPeptide binds in a groove between the bB strand and
the aB helix, oriented antiparallel to bB. The bA–bB well defined in the crystal structure of the PDZ–petide
complex, as shown in a difference electron density mapconnecting loop contains the sequence Gly-Leu-Gly-
Phe, after which PDZ domains were originally named calculated without inclusion of the peptide (Figure 3A).
The strong electron density indicates that this region of(GLGF repeats) (Cho et al., 1992). These amino acids
turn out to play an important functional role in binding the peptide is highly ordered, and it is clear that a single
peptide molecule binds to a single PDZ domain. Thethe C-terminal carboxylate group of the peptide, and
therefore the loop will be referred to as the carboxylate- structure of the peptide in its binding site does not ap-
pear to be distorted by crystal contacts. Two importantbinding loop.
An aspect of the PDZ domain fold shared by other general features of the binding site are emphasized in
a molecular surface representation of the complex: first,modular peptide-binding units such as SH2 domains is
that the N- and C-termini are located near each other the peptide binds in a groove on the surface and, sec-
ond, the C-terminal residue dips into a prominent cavityon the back side of the domain relative to the peptide-
binding site. As in the case of SH2 domains, such an (Figures 3B and 3C). In the following discussion, the
peptide C-terminal valine residue will be referred to asarrangement would allow the domain to be readily trans-
ferred as a functional unit between proteins with the Val 0 and the remaining peptide residues will be num-
bered in descending order as Ser 21, Thr 22, Gln 23,preservation of the peptide-binding site (Kuriyan, 1993).
The structure of the complex reveals that many amino and Lys 24. The lysine side chain is less ordered and
was modeled as an alanine. In the final model, the aver-acids are conserved for functional reasons; these will
be discussed below (see highlighted residues in Figure age main chain temperature factor increased systemati-
cally from 17 A˚2 for Val 0 to 22 A˚2 for Gln 23, suggesting2).Other amino acids clearly are conserved for structural
reasons. For example, the majority of conserved hy- that the peptide is anchored most strongly by its interac-
tions near the C-terminus.drophobic residues contribute to the hydrophobic core,
and several conserved glycine residues are present to The binding site groove for peptide is formed by three
Molecular Basis of Peptide Recognition by PDZ
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Figure 2. Sequence Alignment of Selected
PDZ Domains
The secondary structure elements of PDZ-3
are shown as arrows (b sheet), bars (a helix),
and lines (connecting loops). The residues
contacting peptide in the PDZ-3–peptide
complex and their counterparts in the homol-
ogous domains areshown in gray. Amino acid
numbering corresponds to that of PSD-95.
The sequences are as follows: PDZ-3 (resi-
dues 309–393), PDZ-2 (residues 156–246),
and PDZ-1 (residues 61–151) (all from PSD-
95; Cho et al., 1992), Discs-Large (DLG) (re-
peat 3, residues 482–566; Woods and Bryant,
1991), SAP97 (repeat 3, residues 461–545;
Muller et al., 1995), nNOS (residues 12–100;
Bredt et al., 1991), Torpedo syntrophin (Tor-
Syn) (residues 65–152; Adams et al., 1993),
ZO1 (repeat 2, residues 408–491; Willott et
al., 1993) and ZO2 (residues 93–176; Jesaitis
and Goodenough, 1994), Lin 2a (residues
542–628; Hoskins et al., 1996), and p55 (resi-
dues 67–153; Ruff et al., 1991).
structural elements of the PDZ domain: the carboxylate- also provides an arginine residue (Arg-318) that interacts
with the carboxylate via a highly ordered water molecule.binding loop, bB, and aB (Figure 1). Amino acids from
all three elements make contacts with bound peptide. This arrangement would allow a proton to shift from
the Arg-318 guanidinium toward the carboxylate anionOne important set of interactions arises from main chain
(Figure 4B). In total, the two carboxylate oxygens partici-atoms of the bB strand, which runs the length of the
pate in hydrogen bond formation with three amide nitro-binding site groove. Hydrogen bonds are present be-
gens (from Leu-323, Gly-324, and Phe-325) and the wa-tween the amide nitrogen of Val 0 and the carbonyl of
ter associated with Arg-318. Thus, a very importantPhe-325, between the carbonyl oxygen of Thr 22 and
aspect of peptide recognition by the PDZ domain is itsthe amide nitrogen of Ile-327, and between the amide
ability to stabilize the terminal carboxylate group. Notnitrogen of Thr 22 and the carbonyl oxygen of Ile-327
surprisingly, the amino acid composition of the carbox-(Figures 4A and 4B). These main chain interactions with
ylate-binding loop is conserved among many differentbB are responsible for stabilizing an extended peptide
PDZ domains (Figure 2). The amino acid correspondingin the binding groove and presumably increase the affin-
to Arg-318, for example, is almost always either an argi-ity of the interaction, but they do not account for se-
nine or lysine, and the glycine residues are also quitequence-specific recognition.
conserved. It is interesting to note, however, that someSince PDZ domains recognize the C-terminus of their
more distantly related PDZs show some variability intarget membrane protein, it is interesting to see how
this important region (Figure 2). In particular, variabilityspecificity for the C-terminus is achieved. The carboxyl-
in the Lin 2a and p55 PDZ domains suggests that theyate-binding loop (residues 318–324; Figure 4A) is de-
may interact with a somewhat different peptide recogni-signed for this purpose. The residues Gly-Leu-Gly-Phe
tion sequence.(residues 322–325) within this loop form a cradle of am-
ide nitrogens that hydrogen bond with the terminal car- Three of the four ordered peptide side chains contact
boxylate group. The glycine residues provide the archi- the PDZ domain (Figures 4A and 4B). Beginning at the
23 position on the peptide, the side chain oxygen oftectural flexibility necessary to form the cradle. The loop
Cell
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Figure 3. Peptide-Binding Site on the PDZ-3 Domain
(A) A stereo image of a Fourier map was calculated using coefficients of |Fo|-|Fc|, where Fc is the calculated structure factor from the PDZ-
3–peptide complex with peptide removed. To eliminate model bias, we subjected the partial model to simulated annealing refinement before
calculation of the difference electron density. The map, contoured at 3s, defines the peptide carboxylate group and the last four C-terminal
peptide residues. The model of the peptide and surrounding domain structure is shown. A water molecule, involved in the interaction of the
peptide carboxylate group with the PDZ domain, is shown as a green sphere (drawn using O; Jones et al., 1991). (B) Surface topology of the
PDZ-3 domain highlighting the peptide-binding groove and the hydrophobic pocket into which the peptide valine side chain is inserted. The
C-terminal sequence of the peptide is KQTSV, but here the lysine has been modeled as an alanine owing to peptide disorder. The picture
was generated using the program GRASP (Nicholls et al., 1991). (C) A 2|Fo|2|Fc| electron density map, calculated to 1.82 A˚ resolution and
contoured at 1.4s, shows three of the four residues (Leu-323, Phe-325, and Ile-327) lining the hydrophobic pocket. In the peptide model,
residues are numbered in descending order starting at the C-terminal valine (Val 0).
Gln 23 is involved in hydrogen bond formation with Asn- side chain of His-372 is well positioned toaccommodate
this organization of hydrogen bonds with the threonine326 from bB and with Ser-339 from bC. The hydroxyl
oxygen of Thr 22 hydrogen bonds with the N-3 nitrogen hydroxyl group. These side chain interactions rationalize
the finding that Thr 22 is a critical functional residueof His-372, while the N-1 nitrogen forms a hydrogen
bond with the carbonyl oxygen of Gly-329. Thus, the in the interaction of the Kv1.4 K1 channel (C-terminal
Molecular Basis of Peptide Recognition by PDZ
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Figure 4. Chemical Interactions Involved in Peptide Binding
(A) Stereo view of the peptide-binding site demonstrating protein–
peptide interactions via hydrogen bonds (dashed white lines) and
the location of the Val 0 side chain in the hydrophobic pocket.
Oxygen atoms are shown in red and nitrogen atoms in blue. The
green sphere shows a well-ordered water molecule linking the car-
boxylate group to Arg-318. The picture was drawn with MOLSCRIPT
and Raster3D.
(B) Schematic view of the contacts identified in the crystal structure
of the complex. Dashed lines represent hydrogen bonds, and the
two closest atom-to-atom distances between the Val 0 side chain
and all atoms in the hydrophobic pocket of the PDZ domain are
drawn as solid black lines. The Val 0 side chain makes numerous
other Van der Waals contacts within the range of 3.9 to 4.3 A˚;
however, for clarity they are not indicated in this diagram. The fixed
orientation of the arginine guanidinium head group via hydrogen
bonds with backbone carbonyl groups is also shown.
sequence Glu-Thr-Asp-Val-COO2) with PDZ-2 from peptide residue at position 21, on the other hand, has
been shown to be functionally unimportant and is poorlyPSD-95 in which the histidine residue (corresponding
to position 372) is conserved (Kim et al., 1995). The conserved among the C-termini of membrane proteins
Cell
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Figure 5. Comparison of the Peptide-Bound and Peptide-Free PDZ Domains
The a carbon traces of the peptide-bound (black) and peptide-free (red) PDZ domain are superimposed. The peptide has been deleted. Side
chains that interact with peptide are included. The two coordinate sets were overlapped using a least-squares method by LSQKAB (CCP4
program suite, 1994). The rmsd between the a carbon atoms of the two domains is 0.9 A˚.
thought to interact with PDZ domains. In harmony with model) PDZ-3 domain shows there is little conforma-
tional change associated with peptide binding (Figurethese observations, the side chain of Ser 21 is pointed
into solution, away from the interaction surface. 5). Although the peptide-free structure was used in the
initial estimate of phases for the peptide complex, theC-terminal to the a carbon of Ser 21, the peptide
begins to dip into a cavity on the surface of the domain two models were decoupled by a simulated annealing
step prior to further refinement (see Experimental Proce-(Figures3B, 3C, and 4A). The terminal carboxylate group
is held by atoms from the carboxylate-binding loop in dures). The root-mean-square deviation (rmsd) in a car-
bon positions is 0.9 A˚ between the two models. A signifi-such a way that the side chain of Val 0 projects directly
down into a hydrophobic pocket lined by Leu-323, Phe- cant change is observed in the a carbon positions of
Gly-319, Ser 320, and Thr 321 (by 4.0 A˚, 4.4 A˚, and 3.5325, Ile-327, and Leu-379 (Figures 3C and 4A). This tight
contact between the Val 0 side chain and the hydropho- A˚, respectively; see loop at the top of Figure 5).However,
this conformational change has only a slight effect onbic pocket explains the importance of valine in the rec-
ognition sequence. A mutagenesis study showed a loss the positions of peptide-interacting atoms, and since it
occurs at a crystal contact the relevance of these shiftsof interaction between the Kv1.4 K1 channel C-terminus
and PDZ-2 of PSD-95 when the valine is mutated to to peptide binding is questionable. The side chains of
functionally important amino acids have been includedalanine (Kim et al., 1995). Based on the structure, it is
evident that such a mutation would create an energeti- in the superposition, and only very minor changes in
their disposition are observed. One example is a 1808cally costly unfilled hole within the hydrophobic pocket
(Eriksson et al., 1992). Among the different PDZ do- rotation of the His-372 side chain to form the hydrogen
bond link between Thr 22 on the peptide and Gly-329mains, the four residues lining the hydrophobic pocket
arehighly conserved in theirhydrophobic character. The on the domain. In the peptide-free structure, the rotated
imidazole forms a hydrogen bond with the carbonyl ofminor variation that does exist (for example, Ile→Val in
nNOS and Phe→Ile in Torpedo syntrophin; Figure 2) Ile-327 rather than with that of Gly-329 (via the imidazole
N-3 nitrogen). Not surprisingly, the well-ordered waterraises the interesting possibility of a selectivity mecha-
nism based on the volume of the hydrophobic pocket. molecule linking the peptide terminal carboxylate with
Arg-318 is shifted in its position and is less well definedSuch a mechanism might allow certain PDZ domains to
recognize sequences with a hydrophobic residue other in the peptide-free structure. In summary, however,
these changes are very slight and the overwhelmingthan valine in the last position. In this context, it is inter-
esting to note that the inward rectifier K1 channel IRK1 conclusion is that the uncomplexed PDZ-3 domain waits
poised and ready to engage its specific C-terminalterminates in the sequence Glu-Ser-Glu-Ile-COO2, to
cite one of many examples (Kubo et al., 1993). peptide.
Comparison with PTB and PH DomainsComparison of the Peptide-Bound
and Free Domains Phosphotyrosine-binding domains (PTBs) are recently
described peptide-binding modules that recognize se-A superposition of the crystal structures of the peptide-
free and peptide-bound (with peptide removed from the quences containing phosphotyrosine but are unrelated
Molecular Basis of Peptide Recognition by PDZ
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Figure 6. Schematic Drawing of a PDZ and
an IRS-1 PTB Domain
A shared peptide-binding motif is highlighted
in red. In both domains boundpeptide, shown
in yellow, forms an antiparallel b sheet with
the b strand flanking the peptide-binding
groove. The schematic of the IRS-1 PTB do-
main is based on Zhou et al. (1996).
in sequence and architecture to SH2 domains. Their fold PSD-95 (Kim et al., 1995; Kornau et al., 1995; Nietham-
mer et al., 1996). A database search for membraneis similar to that of Pleckstrin homology (PH) domains,
and it has been suggested that PTB domains are a proteins with the putative PDZ-binding C-terminal se-
quence X-Thr/Ser-X-Val-COO2 has revealed an exten-subset of the PH domain family (Figure 6) (Zhou et al.,
1996). The connectivity of a PDZ domain differs from sive list, in which the 23 position is quite variable (Kor-
nau et al., 1995). We think it is quite likely that variation atthat of a PTB (or PH) domain, but it is interesting to note
that they seem to share a common and possibly novel this 23 position plays a role in determining the selective
pairing of different PDZ domains with their specific pro-peptide binding motif. Not only does the peptide bind
betweena similarly positioned a helix and b sheet in both tein ligand.
A surprisingly large number of membrane proteinsdomains, but the mode of antiparallel b-sheet binding is
similar. other than voltage-dependent K1 channels and gluta-
mate receptor channels terminate in the sequence
X-Thr/Ser-X-Val-COO2, suggesting that they too may
Perspective interact with PDZ domains (Kornau et al., 1995). A list of
From the growing list of proteins whose biological func- potential interacting membrane proteins would include
tion is to bind peptides or short sequences, we have certain inward rectifier K1 channels, Na1 channels, and
learned that nature solves the problem of peptide recog- several G protein–coupled receptors. The determinants
nition using many different structural scaffolds. PDZ do- of peptide recognition defined here, in particular that a
mains present a peptide-binding groove between a b short four-residue C-terminal stretch suffices to engage
sheet and an a helix. The number of ordered peptide the PDZ domain, leaves little doubtthat thesemembrane
amino acids in thebinding site (4) is relatively small when proteins do indeed bind to PDZ domain–containing mol-
compared with othermodular peptide-binding domains, ecules. Since PDZ domains are found either singly or
which typically bind 5 to 10 residues (Stanfield and Wil- multiply in a wide variety of proteins associated with
son, 1995). Nevertheless, the PDZ domain achieves a cell–cell junctions, we predict that multiple differential
comparable number of contacts with its peptide, making interactions with a diverse range of membrane proteins
10hydrogen bonds and burying a solvent-excluded area will underlie the organizing function of these PDZ-con-
of 400 A˚2. In comparison, SH2 domains make 8 to 12 taining molecules.
hydrogen bonds and bury roughly 350 A˚2 to 550 A˚2. A
unique property of the PDZ domain is the organization
Experimental Proceduresof its binding site to accept a C-terminal carboxylate
group. The C-terminus of the peptide plugs into a cavity
Protein Expression and Purificationon the surface, which accommodates the carboxylate
Recombinant PDZ-3 protein was expressed in E. coli (BL21) as a
group near the cavity opening and a hydrophobic side glutathione S-transferase fusion protein (pGEX-4T-1 vector; Phar-
chain at its base. macia). 2 hr following induction with 1-b-D-thiogalactopyranoside,
bacteria were pelleted by centrifugation (6000 rpm, 5 min, GSASpecificity for the C-terminal recognition sequence is
rotor), resuspended in a solution of 140 mM NaCl, 2.7 mM KCl, 10explained by the complexed and peptide-free structures
mM Na2HPO4, 1.8 mM KH2PO4, 1.0 mM dithiothreitol (DTT; pH 7.3)reportedhere. Previousfunctional work on peptide inter-
(180 ml per 1 l of culture), and sonicated immediately after theactions with PDZ domains identified the terminal three
addition of 10 mg/ml pepstatin, 10 mg/ml leupeptin, 0.1 mM phenyl-
residues as being important for binding (Kim et al., 1995; methyl sulphonyl fluoride, and10 mM b-mercaptoethanol. The lysate
Kornau et al., 1995; Niethammer et al., 1996). An impor- was centrifuged(15,000 rpm, 20 min, SS-34 rotor), and fusionprotein
was purified from the supernatant using glutathione–Sepharose 4Btant finding in the structure is that Gln 23 is well ordered
resin according to the standard batch method described in theand makes specific contacts with the PDZ domain, im-
manual (Pharmacia). The PDZ-3 domain was cleaved from the resin-plying that the recognition sequence consists of the
immobilized fusion protein with thrombin (Sigma; 500 U per 1 ml ofC-terminal four amino acids. (Thus, we refer to the rec-
Sepharose bed volume, 4 hr incubation at room temperature) and
ognition sequence as X-Thr/Ser-X-Val-COO2.) Interest- purified to homogeneity using a Mono Q FPLC column (Pharmacia)
ingly, the residue at the 23 position is well conserved run with a linear gradient from buffer A (1.0 mM DTT, 20 mM Tris–HCl
[pH 7.5]) to buffer B (1.0 M NaCl, 1.0 mM DTT, 20 mM Tris–HCl [pHas a glutamate in proteins known to bind to PDZ-2 of
Cell
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Table 1. Data Collection and Refinement Statistics
Data Quality
Reflections Completeness (%) Rmerge (%)a
Dataset Resolution (A˚) measured/unique overall/outer shell overall/outer shell Phasing Powerb Rcullisc
Native 20–2.2 38267/6421 96.6/90.2 3.6/16.6 — —
Mutant S350Cd 20–3.0 24101/2704 97.7/95.8 10.7/39.2 1.04 0.85
Mutant A378Cd 20–2.5 46918/4501 96.5/92.7 6.9/40.7 1.86 0.68
Mutant S398Cd 20–2.5 40396/4605 98.5/99.6 4.9/14.7 1.69 0.71
Osmate 20–3.0 28725/2693 99.2/99.3 6.2/12.5 1.09 0.85
Overall figure of merit, 0.61
Cocrystal 20–1.82 141652/11108 95.7/90.1 4.8/14.4 — —
Refinement
Resolution (A˚) Completeness (%) R factor Free R factore Reflection Number
Native with F . 2sF 6–2.30 98.4 0.214 0.315 5322
Cocrystal with F . 2sF 6–1.82 94.3 0.207 0.278 10737
Bond Lengths Rmsd (A˚) Bond Angles Rmsd (8) B Values Rmsd (A˚2)
Native 0.013 1.8 1.7
Cocrystal 0.013 1.7 1.6
a Rmerge 5 100 3 SS | Ih, i 2 kIhl | / S S Ih, i
h h ii
b Phasing power 5 rms heavy atom structure/rms lack of closure
c Rcullis 5 S || Fderiv 2 Fnat | 2 | FHcalc || /S | Fderiv 2 Fnat |
h h
d Derivatized by soaking in a reservoir solution that contained 1 mM thimerosal for 4 hr.
e Free R factor was calculated with 10% of the data.
7.5]). The protein was then dialyzed against a solution of 10 mM crystals grew at a slower rate than peptide-free PDZ-3 crystals, but
continued to grow for several weeks and producedbetter diffraction.NaCl, 0.5 mM DTT, 10 mM HEPES (pH 7.2), concentrated to 30–50
mg/ml using a Centriprep concentrator (Amicon), and stored at A data set from a single frozen crystal was collected to 1.82 A˚ Bragg
spacings on a large MAR image plate with a rotating anode X-ray2808C. The final protein used for crystallization consisted of amino
acids 302–402 from PSD-95 with 5 additional vector-derived resi- generator (Siemens). The PDZ–peptide complex crystallized in the
same space group as the peptide-free domain with cell constantsdues on the N-terminus (GSPEF) and 13 on the C-terminus
(NSRVNSSGRIVTN). a 5 b 5 c 5 89.3 A˚ and one molecule per asymmetric unit. All data
sets were processed using DENZO and SCALEPACK (Z. Otwinowski
and W. Minor).Peptide Synthesis and Analysis
The 9-mer peptide (TKNYKQTSV) was made at the Harvard Medical
School Biopolymer Facility at 0.25 mmol scale on an Applied Biosys- Structure Determination and Refinement
tems model 430A peptide synthesizer using Fmoc chemistry and The structure of the peptide-free PDZ-3 domain was determined
the FastMoc cycles provided by the manufacturer, modified for by multiple isomorphous replacement. Only a single isomorphous
cappingprior to deprotection andcoupling. At the end of the synthe- heavy atom derivative (osmate) of the wild-type protein was found in
sis, the weight gain was 91% of the theoretical maximum. The an exhaustive heavy atom screen. Therefore, site-directed cysteine
peptide was cleaved from the resin and deprotected with mutagenesis was used to introduce mercury attachment sites. Sin-
TFA:water:ethanediol (95:2.5:2.5) at room temperature for 3 hr, fil- gle site mutations were made using PCR mutagenesis and con-
tered to separate peptide from resin, and then precipitated and firmed by dideoxy sequencing. Mutant protein was expressed and
thoroughly washed in t-butyl ether. Reverse-phase HPLC showed purified in the same manner as the wild type. For each mutant, a
that the unpurified peptide was more than 95% pure. Using MALDI- grid screen around the crystal growth condition for the wild-type
mass spectrometry, the observed mass of the protonated peptide protein was carried out to improve crystal growth and morphology.
was 1069.6, in agreement with the expected mass of 1069.2 g/mol Of the ten cysteine mutants produced, five yielded crystals compa-
(Kriegel et al., 1993). rable with the wild-type protein, and three of these (S350C, A378C,
and S398C), derivatized with Thimerosal (ethylmercurithiosalicylic
acid; Aldrich), gave useful phase information (see Table 1). TheCrystallization and Data Collection
Crystals of the peptide-free PDZ-3 domain were grown using sitting positions of all three heavy atoms were located using SHELX-90
(Sheldrick, 1990) and verified by the calculation of cross-differencedrops equilibrated against a reservoir of 0.8 M sodium citrate and
0.1 M HEPES (pH 7.5). Drops (8 ml) were set up at a 1:1 ratio of Fourier maps using the Collaborative Computational Project 4
(CCP4) program suite (1994). Heavy atom parameter refinementsreservoir to protein solution ata concentration of 15 mg/ml. Nonbire-
fringent bipyrimidal crystals grew over 1 week to a maximum size were performed using MLPHARE (Z. Otwinowski, CCP4 program
suite), and an initial electron density map was calculated to 2.5 A˚of 1 mm on edge. The crystals were cubic (space group P4132,
a 5 b 5 c 5 89.2 A˚), contained a single molecule per asymmetric (overall figure of merit, 0.61) and improved by density modification
(Zhang and Main,1990). The resulting map was readily interpretable,unit, and diffracted to Bragg spacings of 2 A˚. Prior to data collection,
crystals were transferred first into a stabilizing solution (0.9 M so- and model building proceeded with the program O (Jones et al.,
1991).dium citrate, 0.1 M HEPES [pH 7.5]) and then over several hours
into the same solutionplus 20% glycerol for cryoprotection. A native The model was refined using the conventional least-squares pro-
cedure carried out using X-PLOR (Brunger, 1992). The refined model2.2 A˚ data set was collected from a single frozen crystal on a Rigaku
R-AXIS IIC image plate detector mounted on a rotating anode X-ray of the peptide-free PDZ-3 domain at 2.3 A˚ (Table 1) comprises 831
nonhydrogen atoms and 105 water molecules. All residues startinggenerator (Molecular Structure Corporation). Crystals of the PDZ-
3–peptide complex were grown as above, but using a reservoir from the N-terminal residue numbered 304 to the C-terminus of
the recombinant protein were defined. However, owing to disorder,solution of 1.0 M sodium citrate, 0.1 M HEPES (pH 7.5). Box-shaped
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residues E304, E305, D306, and E310 were modeled as alanines. and Snyder, S.H. (1991). Cloned and expressednitric oxide synthase
structurally resembles cytochrome P-450 reductase. Nature 351,The average temperature factors for all main chain and side chain
residues are 23 and 42 A˚2, respectively. The temperature factors for 714–718.
the water molecules range from 19 to 82 A˚2, with an average value Brenman, J.E., Chao, D.S., Xia, H., Aldape, K., and Bredt, D.S. (1995).
of 55 A˚2. The crystallographic R value for the peptide-free PDZ-3 Nitric oxide synthase complexed with dystrophin and absent from
model, using data from 6.0 to 2.3 A˚ (2s cutoff), is 21.4% (Rfree 5 skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell
31.5%; Brunger, 1993). 82, 743–752.
When the crystallographic R value for the peptide-free PDZ-3
Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E.,model was 25.4% (Rfree 5 33.3%), the coordinates were used in
Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F., Froehner,a rigid body refinement procedure using X-PLOR (Brunger, 1992)
S.C., and Bredt, D.S. (1996). Interaction of nitric oxide synthaseagainst the cocrystal data set (Table 1) with data between 8.0 and
with the postsynaptic density protein PSD-95 and a1-syntrophin3.0 A˚ Bragg spacings. The crystallographic R value dropped by
mediated by PDZ domains. Cell 84, 757–767.10% from an initial value of 58%. The rigid body rotational and
translational parameters that produced this result in Eulerian angles Brunger, A.T. (1992). X-PLOR (Version 3.1) Manual (New Haven,
Connecticut: The Howard Hughes Medical Institute and Departmentand angstroms are 0.648, 2.738, and 24.328 and 21.27 A˚, 20.35 A˚,
and 20.17 A˚, respectively. After applying a simulated annealing of Molecular Biophysics and Biochemistry, Yale University).
procedure using data to 2.5 A˚, the location of the bound peptide Brunger, A.T. (1993). Assessment of phase accuracy by cross valida-
was determined from an |Fo|2|Fc| difference electron density map. tion: the free R value. Methods and applications. Acta Cryst. D49,
As the peptide extends away from the domain, the definition of 24–36.
electron density dramatically decreases owing to peptide disorder.
Cho, K.O., Hunt, C.A., and Kennedy, M.B. (1992). The rat brain post-As a result, the last four C-terminal peptide residues out of a total
synaptic density fraction contains a homolog of the Drosophilaof nine residues were well defined and are fully modeled. The fifth
Discs-Large tumor suppressor protein. Neuron 9, 929–942.residue from the C-terminus of the peptide, lysine, could only be
modeled as an alanine with no density for the remaining N-terminal Collaborative Computational Project 4 (CCP4) (1994). The CCP4
suite programs for protein crystallography. Acta Cryst. D50,peptide section. This situation remained unchanged through final
refinement. Therefore, the sequence of the refined modeled peptide 760–763.
is AQTSV. After building in the peptide, multiplecycles of remodeling Eriksson, A.E., Baase, W.A., Zhang, X.-J., Heinz, D.W., Blaber, M.,
using O, and least-squares refinement with resolution extension to Baldwin, E.P., and Matthews, B.W. (1992). Response of a protein
1.82 A˚ (2s cutoff), the final crystallographic R value was 20.7% structure to cavity-creating mutations and its relation to the hy-
(Rfree 5 27.8%). The refined model of the peptide-bound PDZ-3 do- drophobic effect. Science 255, 178–183.
main consists of the entire PDZ-3 recombinant protein (except for
Hall, A.V., Antoniou, H., Wang, Y., Cheung, A.H., Arbus, A.M., Olson,the first five N-terminal residues) and 148 water molecules. Owing
S.L., Lu, W.C., Kau, C.L., and Marsden,P.A. (1994). Structural organi-to disorder, the following side chains were modeled as alanine resi-
zation of the human neuronal nitric oxide synthase gene (NOS1). J.dues: E305, E310, and D332. Average main chain and side chain
Biol. Chem. 269, 33082–33090.temperature factors for the PDZ-3 domain in the complex are 20
and 23 A˚2, respectively, and 21 and 20 A˚2, respectively, for the Hata, Y., Butz, S., and Sudhof, T.C. (1996). CASK: a novel DLG/
PSD95 homolog with an N-terminal calmodulin-dependent proteinpeptide. The average temperature factor for the water molecules is
38 A˚2 for the cocrystal structure. kinase domain identified by interaction with neurexins. J. Neurosci.
16, 2488–2494.Atomic coordinates and X-ray structure factors are being depos-
ited in the Protein Data Bank. In the meantime, they may be obtained Hoskins, R., Hajnal, A., Harp,S., and Kim, S.K. (1996). The C. elegans
electronically from the authors (mackinn@rockvax.rockefeller.edu). vulval induction gene Lin-2 encodes a member of the MAGUK family
of cell junction proteins. Development 122, 97–111.
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